Preclinical Pharmacokinetics and Dosimetry of an (89)Zr Labelled Anti-PDL1 in an Orthotopic Lung Cancer Murine Model.

Krache A, Fontan C, Pestourie C, Bardiès M, Bouvet Y, Payoux P, Chatelut E, White-Koning M, Salabert AS

Open source

DOI
10.3389/fmed.2021.741855
Published
2021
Container
Frontiers in medicine
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2021.741855,
  title = {Preclinical Pharmacokinetics and Dosimetry of an (89)Zr Labelled Anti-PDL1 in an Orthotopic Lung Cancer Murine Model.},
  author = {Krache A and Fontan C and Pestourie C and Bardiès M and Bouvet Y and Payoux P and Chatelut E and White-Koning M and Salabert AS},
  year = {2021},
  journal = {Frontiers in medicine},
  doi = {10.3389/fmed.2021.741855},
  url = {https://doi.org/10.3389/fmed.2021.741855}
}

RIS

TY  - JOUR
TI  - Preclinical Pharmacokinetics and Dosimetry of an (89)Zr Labelled Anti-PDL1 in an Orthotopic Lung Cancer Murine Model.
AU  - Krache A
AU  - Fontan C
AU  - Pestourie C
AU  - Bardiès M
AU  - Bouvet Y
AU  - Payoux P
AU  - Chatelut E
AU  - White-Koning M
AU  - Salabert AS
PY  - 2021
JO  - Frontiers in medicine
DO  - 10.3389/fmed.2021.741855
UR  - https://doi.org/10.3389/fmed.2021.741855
ER  - 

APA

A, K., C, F., C, P., M, B., Y, B., P, P., E, C., M, W., & AS, S. (2021). Preclinical Pharmacokinetics and Dosimetry of an (89)Zr Labelled Anti-PDL1 in an Orthotopic Lung Cancer Murine Model.. Frontiers in medicine. https://doi.org/10.3389/fmed.2021.741855

Source records